Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema

OBJECTIVE: To assess ‘time in range’ as a novel measure of treatment response in diabetic macular oedema (DMO). METHODS: This post hoc analysis of the Protocol T randomised clinical trial included 660 individuals with centre-involved DMO and best-corrected visual acuity (BCVA) letter score ≤78–≥24 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozak, Igor, Pearce, Ian, Cheung, Chui Ming Gemmy, Machewitz, Tobias, Lambrou, George N., Molina, Daniel, Suleiman, Lima, Youssef, Hossam, Bressler, Neil M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630493/
https://www.ncbi.nlm.nih.gov/pubmed/36977936
http://dx.doi.org/10.1038/s41433-023-02507-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630493/
https://www.ncbi.nlm.nih.gov/pubmed/36977936
http://dx.doi.org/10.1038/s41433-023-02507-x

Ejemplares similares